Targeted selection of HIV-specific antibody mutations by engineering B cell maturation

Journal: Science

Published: 2019-12-06

DOI: 10.1126/science.aay7199

Affiliations: 13

Authors: 35

Go to article
Institutions Share
Duke University Health System, United States of America (USA) 0.66
Boston Children's Hospital (BCH), United States of America (USA) 0.09
Harvard University, United States of America (USA) 0.09
The University of Kansas (KU), United States of America (USA) 0.06
NIH NIEHS Intramural Research Division, United States of America (USA) 0.03
U.S. Department of Health and Human Services (HHS), United States of America (USA) 0.03
3M Company, United States of America (USA) 0.03
Bioqual, Inc., United States of America (USA) 0.03

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER